Our findings demonstrate that TREX1 depletion triggers an intrinsic innate immune response through cGAS-STING pathway activation in multiple SCLC chemoresistant models, which leads to decreased cell proliferation rate and survival. This evidence concerns the gene TREX1 and small cell lung carcinoma.